论文部分内容阅读
Objective: To evaluate the exact role of Aurora A inhibitor,MLN8237, in the function of radiosensitization of non-small lung cancer (NSCLC), as well as the clinical significance of Aurora-A, phosph-Aurora A, and p53 expression in NSCLC patients.